Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 589

The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.

SARS-CoV-2 Omicron variant: recent progress and future perspectives

Open access
Fan, Yao, Li, Xiang, Zhang, Lei, Wan, Shu, Zhang, Long, Zhou, Fangfang·2022·Signal Transduction and Targeted Therapy

Abstract

Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there have been a few variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), one of which is the Omicron variant (B.1.1.529). The Omicron variant is the most mutated SARS-CoV-2 variant, and its high transmissibility and immune evasion ability have raised global concerns. Owing to its enhanced transmissibility, Omicron has rapidly replaced Delta as the dominant variant in several regions. However, recent studies have shown that the Omicron variant exhibits reduced pathogenicity due to altered cell tropism. In addition, Omicron exhibits significant resistance to the neutralizing activity of vaccines, convalescent serum, and most antibody therapies. In the present review, recent advances in the molecular and clinical characteristics of the infectivity, pathogenicity, and immune evasion of Omicron variant was summarized, and potential therapeutic applications in response to Omicron infection were discussed. Furthermore, we highlighted potential response to future waves and strategies to end the pandemic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-022-00997-x

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 127 references

Cited by

See all 589

Metadata

Authors
Fan, Y., Li, X., Zhang, L., Wan, S., Zhang, L., & Zhou, F.
Venue
Signal Transduction and Targeted Therapy
Published
2022-04-28
Volume
7
Issue
1
Pages
141-141
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4225112745
Cited by
589
References
127
FWCI
62.15
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 Omicron variant: recent progress and future perspectives. https://app.cochat.ai/papers/10.1038/s41392-022-00997-x
The paper
Fan, Y., Li, X., Zhang, L., Wan, S., Zhang, L., & Zhou, F. (2022). SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-022-00997-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.